image of Novel Synthetic Drugs in Migraine

Novel Synthetic Drugs in Migraine

Publication Year:
2022
Edition:
1st Ed.
Author:
Paolo Martelletti; Lars Edvinsson
ISBN:
978-3-03-095333-1
Print/PDF
Request Info
Add to Ovid Subscription
Access the Book in Ovid
Access the Book in Ovid
  • Description
  • Details
  • Also Recommended
Description
Published in the series Headache, endorsed by the European Headache Federation, this is the first book on the novel synthetic treatment of migraine with ditans (lasmiditan) and gepants (atogepant, ubrogepant, rimegepant, vazegepant).
These drugs will provide additional options for people with migraine put at risk of side effects by other medications or with unsatisfactory response to previous drugs. There is now a sufficient amount of literature published to interest a wide multidisciplinary readership (general physicians, general neurologists, clinical psychologists, neurologists in training, and medical students) facing every day this burdensome disorder in their clinical practice. The book aims therefore at offering an overview of these new drugs for both acute and prophylactic treatments of migraine, covering studies on clinical evidence, tolerability, and the different stages of clinical development.
Details
Platform:
OvidSP
Product Type:
Book
Author:
Paolo Martelletti; Lars Edvinsson
ISBN:
978-3-03-095333-1
Specialty:
  • Pharmaceuticals
Language:
English
Edition:
1st Ed.
Pages:
109
Publication Year:
2022

Request Information

Rely on Ovid as the trusted solution that transforms research into results.
Back To Top